| Pharmaceutical Exports | Manufacture and export of Glucosamine Hydrochloride and sodium/potassium salts, bulk drug intermediates, and nutraceuticals. | FDA-approved facilities, strategic alliances, regulatory expertise, and established export networks. | B2B focus serving pharmaceutical and nutraceutical companies in USA and Europe. | Export of high-purity pharmaceutical intermediates with regulatory certifications. | 31 | 47 | Primarily through sales contracts and supply agreements with international pharmaceutical companies. | Contract-based sales with negotiated pricing aligned to quality and regulatory compliance. | US FDA approvals and growing demand for pharmaceuticals in regulated markets. | |
| Domestic Pharmaceutical Operations | Manufacture and sales of bulk drugs and intermediates within India. | Established manufacturing base and quality assurance for domestic regulatory compliance. | B2B clients including Indian pharma manufacturers and chemical processors. | Specialty chemical intermediates tailored to Indian pharma requirements. | 21 | 33 | Direct sales to domestic pharmaceutical companies and intermediates buyers. | Market-linked pricing and direct sales contracts. | Domestic pharma industry growth and increased demand for quality intermediates. | |
